213 related articles for article (PubMed ID: 12970175)
1. Crystal structure of the heterodimeric complex of LXRalpha and RXRbeta ligand-binding domains in a fully agonistic conformation.
Svensson S; Ostberg T; Jacobsson M; Norström C; Stefansson K; Hallén D; Johansson IC; Zachrisson K; Ogg D; Jendeberg L
EMBO J; 2003 Sep; 22(18):4625-33. PubMed ID: 12970175
[TBL] [Abstract][Full Text] [Related]
2. Physical and functional interactions between liver X receptor/retinoid X receptor and Sp1 modulate the transcriptional induction of the human ATP binding cassette transporter A1 gene by oxysterols and retinoids.
Thymiakou E; Zannis VI; Kardassis D
Biochemistry; 2007 Oct; 46(41):11473-83. PubMed ID: 17887732
[TBL] [Abstract][Full Text] [Related]
3. RXR heterodimerization allosterically activates LXR binding to the second NR box of activating signal co-integrator-2.
Son YL; Park OG; Kim GS; Lee JW; Lee YC
Biochem J; 2008 Mar; 410(2):319-30. PubMed ID: 18031289
[TBL] [Abstract][Full Text] [Related]
4. Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists.
Bennett DJ; Carswell EL; Cooke AJ; Edwards AS; Nimz O
Curr Med Chem; 2008; 15(2):195-209. PubMed ID: 18220775
[TBL] [Abstract][Full Text] [Related]
5. Role of p160 coactivator complex in the activation of liver X receptor.
Huuskonen J; Fielding PE; Fielding CJ
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):703-8. PubMed ID: 14764426
[TBL] [Abstract][Full Text] [Related]
6. X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling.
Fradera X; Vu D; Nimz O; Skene R; Hosfield D; Wynands R; Cooke AJ; Haunsø A; King A; Bennett DJ; McGuire R; Uitdehaag JC
J Mol Biol; 2010 May; 399(1):120-32. PubMed ID: 20382159
[TBL] [Abstract][Full Text] [Related]
7. Ligand-binding regulation of LXR/RXR and LXR/PPAR heterodimerizations: SPR technology-based kinetic analysis correlated with molecular dynamics simulation.
Yue L; Ye F; Gui C; Luo H; Cai J; Shen J; Chen K; Shen X; Jiang H
Protein Sci; 2005 Mar; 14(3):812-22. PubMed ID: 15722453
[TBL] [Abstract][Full Text] [Related]
8. X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation.
Stehlin C; Wurtz JM; Steinmetz A; Greiner E; Schüle R; Moras D; Renaud JP
EMBO J; 2001 Nov; 20(21):5822-31. PubMed ID: 11689423
[TBL] [Abstract][Full Text] [Related]
9. Discovery of substituted maleimides as liver X receptor agonists and determination of a ligand-bound crystal structure.
Jaye MC; Krawiec JA; Campobasso N; Smallwood A; Qiu C; Lu Q; Kerrigan JJ; De Los Frailes Alvaro M; Laffitte B; Liu WS; Marino JP; Meyer CR; Nichols JA; Parks DJ; Perez P; Sarov-Blat L; Seepersaud SD; Steplewski KM; Thompson SK; Wang P; Watson MA; Webb CL; Haigh D; Caravella JA; Macphee CH; Willson TM; Collins JL
J Med Chem; 2005 Aug; 48(17):5419-22. PubMed ID: 16107141
[TBL] [Abstract][Full Text] [Related]
10. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
11. RAR antagonists diminish the level of DNA binding by the RAR/RXR heterodimer.
Poujol N; Margeat E; Baud S; Royer CA
Biochemistry; 2003 May; 42(17):4918-25. PubMed ID: 12718533
[TBL] [Abstract][Full Text] [Related]
12. Ajuba Preferentially Binds LXRα/RXRγ Heterodimer to Enhance LXR Target Gene Expression in Liver Cells.
Fan H; Dong W; Li Q; Zou X; Zhang Y; Wang J; Li S; Liu W; Dong Y; Sun H; Hou Z
Mol Endocrinol; 2015 Nov; 29(11):1608-18. PubMed ID: 26389695
[TBL] [Abstract][Full Text] [Related]
13. Molecular determinants of the interactions between LXR/RXR heterodimers and TRAP220.
Son YL; Lee YC
Biochem Biophys Res Commun; 2009 Jul; 384(3):389-93. PubMed ID: 19410560
[TBL] [Abstract][Full Text] [Related]
14. Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors.
Seol W; Choi HS; Moore DD
Mol Endocrinol; 1995 Jan; 9(1):72-85. PubMed ID: 7760852
[TBL] [Abstract][Full Text] [Related]
15. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
[TBL] [Abstract][Full Text] [Related]
16. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
17. The three-dimensional structure of the liver X receptor beta reveals a flexible ligand-binding pocket that can accommodate fundamentally different ligands.
Färnegårdh M; Bonn T; Sun S; Ljunggren J; Ahola H; Wilhelmsson A; Gustafsson JA; Carlquist M
J Biol Chem; 2003 Oct; 278(40):38821-8. PubMed ID: 12819202
[TBL] [Abstract][Full Text] [Related]
18. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver.
Anderson SP; Dunn C; Laughter A; Yoon L; Swanson C; Stulnig TM; Steffensen KR; Chandraratna RA; Gustafsson JA; Corton JC
Mol Pharmacol; 2004 Dec; 66(6):1440-52. PubMed ID: 15371561
[TBL] [Abstract][Full Text] [Related]
19. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
20. Analysis of crystal structures of LXRbeta in relation to plasticity of the ligand-binding domain upon ligand binding.
Malini N; Rajesh H; Berwal P; Phukan S; Balaji VN
Chem Biol Drug Des; 2008 Feb; 71(2):140-54. PubMed ID: 18221307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
